Role of Pulmonary Vasodilators in Ameliorating Primary Graft Dysfunction Following Lung Transplant

JAMA Surgery ◽  
2021 ◽  
pp. e215857
Author(s):  
Emily Cerier ◽  
Kalvin Lung ◽  
Ankit Bharat
2020 ◽  
Vol 11 (1) ◽  
Author(s):  
Mnahi Bin Saeedan ◽  
Sanjay Mukhopadhyay ◽  
C. Randall Lane ◽  
Rahul D. Renapurkar

AbstractLung transplantation is a treatment option in end-stage lung disease. Complications can develop along a continuum in the immediate or longer post-transplant period, including surgical and technical complications, primary graft dysfunction, rejection, infections, post-transplant lymphoproliferative disorder, and recurrence of the primary disease. These complications have overlapping clinical and imaging features and often co-exist. Time of onset after transplant is helpful in narrowing the differential diagnosis. In the early post transplantation period, imaging findings are non-specific and need to be interpreted in the context of the clinical picture and other investigations. In contrast, imaging plays a key role in diagnosing and monitoring patients with chronic lung allograft dysfunction. The goal of this article is to review primary graft dysfunction, acute rejection, and chronic rejection with emphasis on the role of imaging, pathology findings, and differential diagnosis.


2016 ◽  
Vol 35 (4) ◽  
pp. S87-S88
Author(s):  
Z. Xu ◽  
R. Schuessler ◽  
D. Nayak ◽  
W. Yang ◽  
E. Trulock ◽  
...  

CHEST Journal ◽  
2020 ◽  
Vol 158 (4) ◽  
pp. A2399-A2400
Author(s):  
Vikramjit Khangoora ◽  
Christopher King ◽  
Oksana Shlobin ◽  
Anne Brown ◽  
Shambhu Aryal ◽  
...  

2020 ◽  
Vol 58 (2) ◽  
pp. 379-388
Author(s):  
Anna E Frick ◽  
Stijn E Verleden ◽  
Sofie Ordies ◽  
Annelore Sacreas ◽  
Robin Vos ◽  
...  

Abstract OBJECTIVES Primary graft dysfunction (PGD) remains a major post-transplant complication and is associated with increased morbidity and mortality. Mechanisms evoking PGD are not completely clear, but inflammation plays a central role. We investigated the association between PGD and inflammatory proteins present in immediate postoperative bronchoalveolar lavage. METHODS All double-lung recipients transplanted at our institution from 2002 to 2018 were included in our study. We retrospectively selected 80 consecutive lung transplant recipients with different PGD grades (n = 20 for each PGD grades 0–1 to 2–3). In bronchoalveolar lavage performed within the first 24 h after donor aortic cross-clamping following lung transplantation, concentrations of 30 cytokines, chemokines and growth factors were assessed by enzyme-linked immunosorbent assay (ELISA) and correlated with donor and recipient demographics and outcomes. For analysis, 2 groups were defined: ‘mild’ PGD (grade 0–1) and ‘severe’ PGD (grades 2–3). RESULTS Significant differences between mild and severe PGD were found in 8 biomarkers [interleukin (IL)-6, IL-10, IL-13, eotaxin, granulocyte colony-stimulating factor, interferon γ, macrophage inflammatory protein 1α, surfactant protein D (SP-D); P < 0.05]. Increased IL-10 and IL-13, but none of the other proteins, were associated with short-term outcome (longer time to extubation; P = 0.005 and P < 0.0001; increased intensive care unit stay; P = 0.012 and P < 0.0001; and hospital stay; P = 0.041 and P = 0.002). There were no significant differences in donor and recipient characteristics between the groups. CONCLUSIONS Expression profiles of key inflammatory mediators in bronchoalveolar lavage fluid differed significantly between lung transplant recipients with severe versus mild PGD and correlated with clinical outcome variables. Further research should focus on the early mechanisms leading to PGD.


2016 ◽  
Vol 16 (2) ◽  
pp. 724-726 ◽  
Author(s):  
J. M. Diamond ◽  
R. J. Shah ◽  
E. Cantu ◽  
M. K. Porteous ◽  
J. D. Christie

Sign in / Sign up

Export Citation Format

Share Document